本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

德纳维制药

10.58
-0.3200-2.94%
盘后10.580.00000.00%19:36 EDT
成交量:384.09万
成交额:4,068.60万
市值:12.70亿
市盈率:-22.56
高:10.88
开:10.72
低:10.56
收:10.90
数据加载中...
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/14

重要事件披露

Form 8-K - Current report
2023/09/02

重要事件披露

Form 8-K - Current report
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities